Redwood Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-229,287
Closed -$8.8M 138
2019
Q1
$8.8M Sell
229,287
-5,676
-2% -$217K 0.64% 77
2018
Q4
$8.3M Sell
234,963
-436
-0.2% -$15.8K 0.78% 64
2018
Q3
$9.06M Sell
235,399
-7,647
-3% -$267K 0.71% 74
2018
Q2
$7.95M Sell
243,046
-3,624
-1% -$109K 0.55% 81
2018
Q1
$6.74M Sell
246,670
-28,282
-10% -$769K 0.48% 87
2017
Q4
$6.82M Buy
274,952
+15,832
+6% +$437K 0.48% 91
2017
Q3
$7.56M Sell
259,120
-185,274
-42% -$5.12M 0.86% 59
2017
Q2
$12.3M Sell
444,394
-70,896
-14% -$1.88M 1.24% 23
2017
Q1
$12.8M Sell
515,290
-51,067
-9% -$1.24M 1.27% 21
2016
Q4
$12.3M Buy
+566,357
New +$12.4M 1.11% 35

Other funds holding BSX

Redwood Investments's BSX Position: Q2 2019 in Review

Redwood Investments sold out of Boston Scientific (BSX) in Q2 2019, closing a stake of 229,287 shares — an estimated $8.8M sold.

Redwood Investments first reported a position in BSX in Q4 2016 and held it in 10 quarters. The position peaked at $12.8M in Q1 2017. 757 funds tracked by Wall St. Rank hold BSX as of Q2 2019.

  • Redwood Investments reported no remaining Boston Scientific position as of Q2 2019 after selling out during the quarter.
  • Redwood Investments sold 229,287 Boston Scientific shares in Q2 2019, an estimated $8.8M.
  • Redwood Investments first reported a position in Boston Scientific in Q4 2016 and held it in 10 quarters.
  • Redwood Investments's Boston Scientific position peaked at $12.8M in Q1 2017.
  • 757 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2019.

Based on Redwood Investments's 13F filing for Q2 2019, filed 26 Jul 2019.